Related Experiment Video
Updated: Jul 5, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations
Hyun-Ja Nam1, Sujeong Kim, Min-Woo Lee
1Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, South Korea.
Abstract:
Growth factors accelerate G0 to S progression in the cell cycle, however, the roles of growth factors in other cell cycle phases are largely unknown. Here, we show that treatment of HeLa cells with hepatocyte growth factor (HGF) at G2 phase induced the G2/M transition delay as evidenced by FACS analysis as well as by mitotic index and time-lapse analyses. Growth factors such as epidermal growth factor (EGF) and fibroblast growth factor (FGF) also induced G2/M transition delay like HGF. HGF treatment at G2 phase causes a delayed activation of cyclin B1-associated kinase and a diminished nuclear translocation of cyclin B1. Either U0126, a MAPK kinase (MEK) inhibitor, or kinase-dead mutant of ribosomal S6 kinase (RSK) abolished the delay. Additionally, knockdown of RSK1, but not RSK2, with siRNA abrogated the delay, indicating that the extracellular-regulated protein kinase (ERK)-RSK1 mediates the HGF-induced delay. We further found that the delay in G2/M transition of cells expressing oncogenic HGF receptor, M1268T, was abolished by RSK1 knockdown. Intriguingly, we observed that HGF induced chromosomal segregation defects, and depletion of RSK1, but not RSK2, aggravated these chromosomal aberrations. Taken together, the ERK-RSK1 activation by growth factors delays G2/M transition and this might be required to maintain genomic integrity during growth factor stimulation.
Insights
Growth factors like HGF can delay the G2/M cell cycle transition, mediated by ERK-RSK1 signaling. This delay may be crucial for maintaining genomic integrity during growth factor stimulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Growth factors typically accelerate cell cycle progression from G0 to S phase.
- The specific roles of growth factors in other cell cycle phases, particularly G2/M, remain largely unexplored.
Purpose of the Study:
- To investigate the impact of growth factors, specifically hepatocyte growth factor (HGF), on the G2/M transition in HeLa cells.
- To elucidate the molecular mechanisms underlying HGF-induced G2/M delay and its potential role in maintaining genomic stability.
Main Methods:
- HeLa cells were treated with HGF, epidermal growth factor (EGF), and fibroblast growth factor (FGF).
- Cell cycle progression was analyzed using Fluorescence-Activated Cell Sorting (FACS), mitotic index counts, and time-lapse microscopy.
- Key molecular players including cyclin B1, MAPK kinase (MEK), ribosomal S6 kinase (RSK), and extracellular-regulated protein kinase (ERK) were assessed.
- RNA interference (siRNA) was used to knockdown RSK1 and RSK2.
- Chromosomal segregation and aberrations were analyzed.
Main Results:
- HGF treatment at G2 phase induced a delay in G2/M transition, a phenomenon also observed with EGF and FGF.
- HGF treatment delayed cyclin B1-associated kinase activation and diminished its nuclear translocation.
- The G2/M delay was abolished by a MEK inhibitor (U0126) or a kinase-dead RSK mutant.
- Knockdown of RSK1, but not RSK2, abrogated the HGF-induced G2/M delay, implicating the ERK-RSK1 pathway.
- Cells expressing an oncogenic HGF receptor showed abolished G2/M delay upon RSK1 knockdown.
- HGF induced chromosomal segregation defects, which were exacerbated by RSK1 depletion.
Conclusions:
- Growth factor stimulation, via the ERK-RSK1 pathway, can delay G2/M cell cycle transition.
- This delay appears to be a protective mechanism to maintain genomic integrity during active growth factor signaling.
- The findings highlight a novel role for growth factors in regulating cell cycle checkpoints beyond the G0/S transition.
Related Concept Videos
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

